Glaucoma can destroy half your optic nerve before you notice anything wrong. Half. It is not a condition you can feel coming. That is exactly why regular eye examinations save sight.
Glaucoma is a group of conditions in which the optic nerve, the cable that carries visual information from the eye to the brain, is progressively damaged. As nerve fibres are lost, the visual field gradually shrinks, typically starting from the periphery and working inward. The most common form causes no pain, no redness, and no noticeable change in vision until a great deal of damage has already occurred. Glaucoma is the leading cause of irreversible blindness worldwide. The nerve damage it causes cannot be undone, but with early detection and consistent treatment it can almost always be halted or slowed enough to preserve functional vision for life.
What You Need to Know About Glaucoma
- Most glaucoma causes no symptoms until significant and permanent nerve damage has occurred. Regular eye examinations are the only reliable way to detect it early
- Elevated intraocular pressure (IOP) is the main risk factor and the primary target of all treatments
- Glaucoma cannot be cured, but it can be controlled: treatment prevents further damage rather than restoring what has been lost
- First-degree relatives of people with glaucoma have a 4 to 9 times higher risk and should have regular eye examinations from their 40s
- Treatment must be continued for life. Stopping drops, even when vision feels completely normal, allows pressure to rise and damage to continue
- Most people with well-managed glaucoma retain good functional vision throughout their lives
What Happens to the Optic Nerve
The optic nerve is made up of around 1.2 million nerve fibres, each carrying visual information from a specific point on the retina. In glaucoma, these fibres are progressively lost. The nerve head, where the optic nerve exits the eye, has a central cup surrounded by a rim of healthy nerve tissue. As fibres are lost, this cup enlarges and the rim thins. The ratio between cup size and disc size, the cup-to-disc ratio, is one of the key measurements ophthalmologists track.
Because the peripheral nerve fibres are typically lost first, and because the brain is remarkably good at compensating for gradual change, most patients don’t notice their visual field shrinking until it has contracted substantially. By the time a person is aware that something is wrong with their peripheral vision in daily life, they may have already lost 40 percent or more of their optic nerve fibres. This is what makes glaucoma so dangerous: it has usually been present for years before it is felt.
Types of Glaucoma
Primary open-angle glaucoma
Primary open-angle glaucoma (POAG) is the most common type, accounting for around 90 percent of glaucoma in Western populations. The drainage angle of the eye remains anatomically open but drains inefficiently. Aqueous humour gradually builds up, raising intraocular pressure (IOP). The elevated pressure slowly damages the optic nerve over months and years, with no pain and no warning. It can progress for years without being detected unless eye examinations include optic nerve assessment and IOP measurement.
Normal tension glaucoma is a form of POAG in which optic nerve damage progresses despite IOP readings within the statistically normal range. The optic nerve appears unusually vulnerable to pressure even at levels that don’t damage most people’s nerves. The treatment approach is the same: lower the IOP further, and progression slows. Counterintuitive if the pressure was “normal” to begin with, but it works.
Primary angle-closure glaucoma
Angle-closure glaucoma occurs when the drainage angle of the eye is physically narrowed or blocked by the iris. It is more common in people with small, crowded eyes, in women, and in people of East and South Asian ancestry. Chronic angle closure progresses silently like open-angle glaucoma. Acute angle closure is different entirely: a medical emergency in which IOP rises to very high levels within hours, causing severe eye pain, headache, nausea, vomiting, blurred vision, and halos around lights. People with narrow angles can be treated preventively with a laser procedure (peripheral iridotomy) before acute closure occurs.
Secondary glaucomas
Secondary glaucomas develop as a consequence of another eye condition or systemic factor. Common causes include pseudoexfoliation syndrome, pigment dispersion syndrome, uveitis, trauma, neovascular glaucoma from diabetic retinopathy or retinal vein occlusion, and prolonged corticosteroid use. Steroid-induced glaucoma is underrecognised: any patient using steroid eye drops regularly should have their IOP monitored. See our steroids in eye care page for more on this.
Risk Factors
Elevated intraocular pressure
Raised IOP is the strongest known risk factor for glaucoma and the primary target of treatment. Normal IOP is generally considered to be between 10 and 21 mmHg, but this is a statistical definition rather than a safe threshold for every individual. An IOP that causes no damage in one person may cause significant optic nerve damage in another whose nerve is more vulnerable.
Age, family history, and ethnicity
POAG affects around 2 percent of people over 40 and rises to around 10 percent over 80. Having a first-degree relative with POAG increases personal risk by four to nine times. People of African or Caribbean ancestry have a three to four times higher risk than white Europeans, tend to develop it younger, and often have a more aggressive course. People of East and South Asian ancestry have elevated risk of angle-closure glaucoma.
High myopia
Severe short-sightedness (myopia greater than minus 6 dioptres) is an independent risk factor for POAG. The highly stretched optic nerve head and the altered anatomy of the myopic eye increase vulnerability to pressure-related damage. People with high myopia should be monitored for glaucoma as part of their regular eye care.
Diagnosis and Monitoring
Intraocular pressure and optic nerve assessment
IOP is measured with a tonometer, most commonly by applanation tonometry at the slit lamp. A single reading is a snapshot: IOP fluctuates throughout the day. Elevated IOP alone does not diagnose glaucoma and must be combined with optic nerve assessment. OCT scanning measures the retinal nerve fibre layer thickness with micrometric precision, detecting thinning that can precede detectable visual field loss by months to years. Fundus photography documents the optic nerve head and allows comparison over time.
Visual field testing
Automated visual field testing maps the peripheral and central visual field, detecting the characteristic pattern of loss caused by glaucoma: arcuate scotomas, nasal steps, and in advanced disease progressive constriction of the remaining field. Serial tests over time are compared to detect statistically significant progression, which directly informs whether treatment needs to be intensified.
Treatment
All current glaucoma treatments lower intraocular pressure. This doesn’t reverse existing damage but slows or halts further progression. The target pressure is individualised based on the stage of disease, rate of progression, and the patient’s life expectancy.
Pressure-lowering eye drops
Eye drops are the most widely used first-line treatment. Prostaglandin analogues (latanoprost, bimatoprost, travoprost) are the most effective single agents, reducing IOP by 25 to 35 percent, used once daily at night. Beta-blockers, carbonic anhydrase inhibitors, alpha-2 agonists, and newer agents such as rho kinase inhibitors each work by different mechanisms and can be combined when a single agent is insufficient. Adherence to drops is one of the most important determinants of long-term outcome and one of the most commonly underestimated challenges in glaucoma management.
Selective laser trabeculoplasty (SLT)
SLT uses a low-energy laser to stimulate the trabecular meshwork cells and improve aqueous drainage. It is effective, safe, repeatable, and increasingly used as a first-line treatment rather than a second-line addition. The LIGHT trial demonstrated that SLT as first-line treatment achieved IOP control comparable to drops in most patients, with many remaining drop-free for years. Five minutes per eye in the clinic, well tolerated.
Surgery
When drops and laser are insufficient, surgery is considered. Trabeculectomy creates a new drainage channel from inside the eye to beneath the conjunctiva. Highly effective but requires careful postoperative management over weeks. Minimally invasive glaucoma surgery (MIGS) describes a group of newer, safer procedures with a more modest pressure-lowering effect but a much better safety profile, suitable for mild to moderate disease. Drainage implants (tubes) are used in complex or refractory cases.
Living With Glaucoma: What Patients Ask Most
Will I go blind? The vast majority of people diagnosed at a reasonably early stage who take their drops and attend appointments maintain functional vision for life. The risk of blindness is much higher in those diagnosed late, who don’t take their drops consistently, or who don’t attend regular monitoring.
Can I drive? Many people with glaucoma continue driving for years. Fitness to drive depends on the extent of visual field loss and whether it meets the legal standard. Your ophthalmologist is required to advise you if they believe your vision no longer qualifies. If you have any doubt, discuss it rather than assuming.
Does exercise, diet, or sleep position affect glaucoma? Vigorous exercise generally lowers IOP slightly and is beneficial. Sleeping with the affected eye pressed against a pillow can raise IOP in that eye. Inverted yoga positions raise IOP sharply during the posture and are best avoided. Drinking large volumes of fluid quickly can transiently raise IOP. None of these factors replace medical treatment, but they are worth knowing about.
Seek Emergency Care Immediately If You Have
- Sudden severe pain in one eye, accompanied by headache and nausea or vomiting
- Suddenly blurred vision with halos or rainbow rings around lights
- A red, painful eye with reduced vision rather than simple irritation
- Any of the above, especially if you have been told you have narrow angles
These symptoms describe acute angle-closure glaucoma, a medical emergency in which IOP rises to very high levels within hours. It can cause permanent severe vision loss if not treated urgently. Go directly to an emergency eye clinic or hospital emergency department. Acute angle closure is completely different from common painless open-angle glaucoma and requires immediate treatment.
Frequently Asked Questions About Glaucoma
-
I have been told my pressure is high but I don’t have glaucoma yet. What does this mean?
This is called ocular hypertension: elevated IOP without any detectable optic nerve damage or visual field loss at the time of testing. It’s a risk factor for glaucoma, not glaucoma itself. Whether to treat with drops depends on the level of pressure, your optic nerve appearance, corneal thickness, age, and other factors. Some people with ocular hypertension are monitored without treatment; others are treated to reduce the risk of conversion. Your ophthalmologist will discuss what makes sense for your specific situation.
-
My drops are making my eyes red and irritated. Can I stop?
Don’t stop without speaking to your ophthalmologist first. This comes up more often than you might think, and there’s almost always a better alternative. Even a short break allows IOP to rise and can cause further optic nerve damage. If a drop is causing side effects, there are almost always alternative agents or preservative-free formulations that are better tolerated. Preservative-free versions cause far less surface irritation and are available for most drop classes. Call the clinic if the symptoms are significant rather than waiting for your next scheduled appointment.
-
How often do I need to be seen?
That depends on the stability and severity of your glaucoma. Newly diagnosed patients and those with unstable or advanced disease are typically reviewed every three to four months. Stable, well-controlled early glaucoma may be reviewed every six to twelve months. Most guidelines recommend at least two visual field tests and two OCT scans per year for patients in active monitoring.
-
My pressure is normal on treatment. Can I reduce my drops?
The normal pressure is because the drops are working. Remove the drops, and the pressure goes back up. Reducing them without medical guidance allows IOP to rise and damage to resume. Some patients whose pressure is very well controlled over years, particularly after laser or surgery, may be able to reduce drops with careful monitoring. That decision should always be made with your ophthalmologist and followed by more frequent IOP checks to confirm pressure remains controlled.
-
Does what I eat or drink affect glaucoma?
Diet doesn’t have a major direct effect for most patients. A few practical things are worth knowing, though. Drinking large volumes of fluid quickly can transiently raise IOP. Caffeine raises IOP slightly for an hour or two after consumption, though habitual coffee drinkers develop tolerance. A diet rich in leafy green vegetables has been associated with modest benefits in some studies. Avoiding smoking is beneficial, as it worsens vascular supply to the optic nerve.
-
Should my children or siblings be tested?
Yes. First-degree relatives have a much higher risk and should have regular eye examinations including optic nerve assessment and IOP measurement from around age 40, or earlier if there’s any concern. Family history alone is sufficient reason for proactive monitoring. Tell your relatives. Encouraging them to have their eyes checked is genuinely one of the most useful things a glaucoma patient can do.
If you would like to learn more, the Centers for Disease Control and Prevention’s glaucoma page offers a clear overview of glaucoma, risk factors, and why regular eye exams matter, while the Glaucoma Research Foundation website provides more detailed patient-friendly information about testing, treatment, and living with glaucoma.
